Evidence map›Paper›PMID 42258210›Full record

ArticleJAMA network open2026

Subfecundity, Infertility Treatment, and Child Neurodevelopment.

Linda G Kahn, Alison E Hipwell, Joseph B Stanford, Noya Galai, Haozuo Zhao, Akram N Alshawabkeh, Judy L Aschner, Emily S Barrett, Ricardo P Bertolla, Kim Nail Cajachagua Torres and 21 more

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Linda G KahnNew York University Grossman School of Medicine, New York, New York.
Alison E HipwellUniversity of Pittsburgh, Pittsburgh, Pennsylvania.
Joseph B StanfordUniversity of Utah, Salt Lake City.
Noya GalaiJohns Hopkins University, Baltimore, Maryland.
Haozuo ZhaoJohns Hopkins University, Baltimore, Maryland.
Akram N AlshawabkehNortheastern University, Boston, Massachusetts.
Judy L AschnerHackensack Meridian School of Medicine, Nutley, New Jersey.
Emily S BarrettRutgers School of Public Health, Piscataway, New Jersey.
Ricardo P BertollaWayne State University School of Medicine, Detroit, Michigan.
Kim Nail Cajachagua TorresNew York University Grossman School of Medicine, New York, New York.
Carlos A CamargoHarvard University Medical School, Boston, Massachusetts.
Jose F CorderoUniversity of Georgia, Athens.
Lisa A CroenKaiser Permanente Northern California Division of Research, Pleasanton.
Sean C DeoniBill and Melinda Gates Foundation, Seattle, Washington.
Semsa GogcuAtrium Health Wake Forest Baptist, Winston-Salem, North Carolina.
Julie B HerbstmanColumbia University Mailman School of Public Health, New York, New York.
Margaret R KaragasDartmouth University Geisel School of Medicine, Hanover, New Hampshire.
Kaja Z LeWinnUniversity of California, San Francisco, San Francisco.
Kristen LyallDrexel University, Philadelphia, Pennsylvania.
Cynthia T McEvoyOregon Health and Science University, Portland.
Kimberlee McKayAvera Research Institute, Sioux Falls, South Dakota.
Thomas G O'ConnorUniversity of Rochester Medical Center, Rochester, New York.
J Richard PilsnerWayne State University School of Medicine, Detroit, Michigan.
Susan L SchantzUniversity of Illinois at Urbana-Champaign, Champaign.
Rebecca J SchmidtUniversity of California, Davis.
Alicia K SmithEmory University School of Medicine, Atlanta, Georgia.
Greta N WilkeningUniversity of Colorado School of Medicine, Aurora.
E ZhangUniversity of Kansas Medical Center, Kansas City.
Yeyi ZhuKaiser Permanente Northern California Division of Research, Pleasanton.
Akhgar GhassabianNew York University Grossman School of Medicine, New York, New York.
ECHO Cohort Consortium

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

Importance: Increasing numbers of children are conceived using infertility treatment; concerns remain about potential effects on child neurodevelopment. Objective: To evaluate whether infertility treatment is associated with child neurodevelopment and whether such an association may be attributable to underlying subfecundity. Design, Setting, and Participants: This cohort study was conducted among mother-child dyads in the National Institutes of Health Environmental Influences on Child Health Outcomes Cohort, with infants conceived between 1998 and 2022. Associations of subfecundity and infertility treatment with neurodevelopmental outcomes were assessed among children ages 2 to 10 years. Data were analyzed from May 14, 2025, to March 31, 2026. Exposure: Subfecundity was defined as prior consultation for, treatment of, or diagnosis of infertility for either partner; at least 2 prior miscarriages; or ever having had unprotected heterosexual intercourse for 12 months without conceiving. Infertility treatment was categorized as in vitro fertilization (IVF) or non-IVF treatment. Main Outcomes and Measures: Harmonized caregiver responses to the Strengths and Difficulties Questionnaire and the Child Behavior Checklist yielded continuous raw scores for externalizing and internalizing problems. The total raw Social Responsiveness Scale (SRS) score quantified autism-like symptoms. Caregivers reported physician diagnosis of autism spectrum disorder (ASD) and attention deficit/hyperactivity disorder (ADHD). Results: Among 15 382 mother-infant dyads, there were 14 191 unique maternal participants (mean [SD] age at delivery, 30.9 [5.33] years; 8780 parous participants [57.1%]). ASD and ADHD were diagnosed in 876 offspring (7.6%) and 819 offspring (7.1%), respectively. In generalized linear models, subfecundity was associated with higher externalizing problem and SRS scores among all pregnancies (externalizing problems: b = 0.47 [95% CI, 0.14-0.81]; SRS score: b = 1.08 [95% CI, 0.01-2.14]) and when restricted to natural conceptions (externalizing problems: b = 0.45 [95% CI, 0.07-0.83]; SRS score: b = 1.12 [95% CI, -0.09 to 2.34]). Offspring of parents with subfecundity had higher odds of ASD (overall: odds ratio [OR], 1.27 [95% CI, 1.03-1.57]; natural conceptions: OR, 1.31 [95% CI, 1.04-1.64]). Children conceived via non-IVF treatment had higher odds of ADHD compared with those conceived via natural conception with subfecundity (OR, 1.77 [95% CI, 1.16-2.68]) or without subfecundity (OR, 1.54 [95% CI, 1.05-2.25]). There were no significant associations for IVF treatment. Conclusions and Relevance: In this large US cohort study, subfecundity was associated with elevated scores for caregiver-reported symptoms of behavioral problems and higher odds of ASD diagnosis, independent of infertility treatment. Non-IVF treatment was associated with ADHD, warranting further research into specific indications for treatment that may increase risk of offspring neurodevelopmental problems.

Indexed as

Child DevelopmentFertilization in VitroInfertilityNeurodevelopmental DisordersAdultChildChild, PreschoolCohort StudiesFemaleHumansMaleNeurodevelopmentPregnancyUnited States

Identifiers

PMID42258210
PMCPMC13247815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.